
Hitachi, Tohoku University and Kyoto University Become World’s First to Establish Technology for Highly Efficient, High-quality Production of Actinium-225, a Material Required for Internal Radiation Therapy Called TAT
TOKYO, Oct 19, 2021 – (JCN Newswire via SEAPRWire.com) – Hitachi, Ltd. (TSE: 6501), Tohoku University and Kyoto University have become the world’s first (1) to establish technology for the highly efficient and high-quality production of actinium-225 (225Ac), a substance required for a form of radiation therapy known as targeted alpha therapy (TAT). TAT is... » read more